Skip to main content
Frontiers in Chemistry logoLink to Frontiers in Chemistry
. 2014 Jul 18;2:49. doi: 10.3389/fchem.2014.00049

Nanoparticles from renewable polymers

Frederik R Wurm 1,*, Clemens K Weiss 2,*
PMCID: PMC4102895  PMID: 25101259

Abstract

The use of polymers from natural resources can bring many benefits for novel polymeric nanoparticle systems. Such polymers have a variety of beneficial properties such as biodegradability and biocompatibility, they are readily available on large scale and at low cost. As the amount of fossil fuels decrease, their application becomes more interesting even if characterization is in many cases more challenging due to structural complexity, either by broad distribution of their molecular weights (polysaccharides, polyesters, lignin) or by complex structure (proteins, lignin). This review summarizes different sources and methods for the preparation of biopolymer-based nanoparticle systems for various applications.

Keywords: nanoparticles, polymers, biodegradation, formulation of nanoparticles

Introduction

Nanoparticles have become omnipresent in science but also have found their ways in a plethora of everyday consumer goods. Synthetic inorganic nanoparticles find application from catalysts to sunscreens and are made from a wide variety of materials, ranging from metals or alloys, to semiconductors, oxides or other ceramic materials (Daniel and Astruc, 2004; Astruc et al., 2005; Kamat, 2007; Vallet-Regi et al., 2007; Na et al., 2009; Becker et al., 2010; Muñoz-Espí et al., 2012). In contrast to these materials, polymeric nanoparticles are designed synthetically for manifold applications. Typically, common vinyl monomer-based polymers, such as polystyrene, polyalkyl(meth)acrylates, few polyesters and polyurethanes are used. Most of them are of synthetic origin. Functionality is added to the particles by chemical modification of the surface. In addition to the general discussion about sustainability (Musto, 2013), and the drive to use “green” processes or raw materials, the naturally occurring polymers or monomers-derived from natural resources- offer great potential for broadening the scope of materials for the preparation of polymeric nanoparticles. In this review, we will briefly introduce polymers and monomers, which are of natural origin or derived from renewable sources, and present some of their unique properties. Subsequently, suitable formulation techniques are discussed and we conclude with recent examples and an outlook to potential future applications.

We will only discuss and present nanoparticle systems and, although there are several examples, not refer to microparticles, including microgels.

Polymers and monomers from natural resources

Polymers from natural resources accompanied mankind throughout history. There is archeological evidence for the use of flax fibers, consisting of cellulose, other polysaccharides, and lignin, already 30,000 years ago (Kvavadze et al., 2009). Although animal derived materials had found their use before, evidence for the use of wool, fur, silk or leather, which are animal derived, protein (keratin, collagen, silk protein) materials, is dating back almost 7000 years (Good et al., 2009). Ancient Mesoamerican people used natural rubber (polyisoprene) in its liquid or colloidal form as medicines, and in its solid form for creating decorative items, coatings, and solid balls to be used in ritual ball games (Hosler, 1999). Widespread application for rubber, however, was enabled by the invention of vulcanization of natural rubber by Goodyear in the nineteenth century. Although polymers from renewable resources have been used for millennia, the recent years witnessed enormous efforts to use plants, animals or microbes as sources for polymers or monomers as alternatives to fossil oil-derived systems, especially in pursuit to match physical, chemical and mechanical properties of synthetic polymers. Extensive literature with excellent reviews presenting details on the different materials have been published recently (Gandini and Belgacem, 1997; Lora and Glasser, 2002; Luengo et al., 2003; Yu et al., 2006; Gandini, 2008, 2011; Kim et al., 2008; Sharma and Kundu, 2008; Vemula and John, 2008; Calvo-Flores and Dobado, 2010; Madhavan Nampoothiri et al., 2010; Mutlu and Meier, 2010; Raquez et al., 2010, 2013; Biermann et al., 2011; Montero de Espinosa and Meier, 2011; Fernandes et al., 2013; Lligadas et al., 2013; Mosiewicki and Aranguren, 2013; Auvergne et al., 2014; Miao et al., 2014). Here, we present a brief overview of some prominent types of polymers and monomers, highlighting their properties and their potential benefits for potential applications of nanoparticulate materials.

Polysaccharides

Natural polysaccharides are ideal materials for the preparation of nanoparticles for drug or protein delivery due to many advantages over synthetic polymers such as natural abundance, generally low cost, ease of manipulation, facile derivatization due to the presence of several nucleophilic groups and, in most cases, biocompatibility. Polysaccharides have a high number of functional groups, a wide range of molecular weights with varying chemical and structural compositions, which contribute to their diversity in structure and in physical property. Due to the presence of various derivable groups on the molecular chains, polysaccharides can be easily modified chemically and biochemically, resulting in many kinds of polysaccharide derivatives. As these biomaterials occur naturally, they are typically very stable, hydrophilic, non-toxic and biodegradable. Particularly, most of natural polysaccharides have hydrophilic groups such as hydroxyl (Figure 1), carboxyl and amino groups, which could form non-covalent bonds with biological tissues (mainly epithelia and mucous membranes).

Figure 1.

Figure 1

Dextran as an example of a branched polysaccharide with multiple hydroxyl groups as functional moieties.

Polyesters

Polyesters such as polylactide (PLA) (Figure 2) or copolymers of poly(lactide-co-glycolide) (Figure 3) are biocompatible and biodegradable materials that are already used as commodity plastics (Gupta and Kumar, 2007; Madhavan Nampoothiri et al., 2010; Kfoury et al., 2013; Raquez et al., 2013) and also widely used in biomedical applications such as drug delivery or in tissue engineering.

Figure 2.

Figure 2

Schematic synthesis of poly(lactic acid) from lactide.

Figure 3.

Figure 3

Structure of poly(lactic acid-co-glycolic acid).

This is mainly due to their safe degradation profile and their commercial availability. They have been approved by the United States Food and Drug Administration (FDA) and European Medicine Agency (EMA) for diverse biomedical applications (drug delivery devices, sutures, and implants). As polylactide is a readily available thermoplastic, biodegradable polyester based on renewable resources, it is a promising material for present and future applications, which substitute fossil materials. The monomer lactic acid (or lactide, the cyclic dilactone) is chiral, having two possible enantiomers (D and L), which can be polymerized enantiomerically pure or in their racemic form: poly(L-lactide) (PLLA) or poly(D-lactide) (PDLA), and the racemic mixture, i.e., poly(D,L-lactide) (PDLLA). Polylactides with an L-content above 90% are crystalline materials, while PDLLA is an amorphous polymer due to the random orientation of the pendant methyl side chain. For applications, semicrystalline PLA is often preferred over the amorphous materials especially when higher mechanical stability is necessary (tensile strength ca. 50–70 MPa). PLA has a glass transition temperature (Tg) between 50 and 65°C and a melting temperature (Tm) of ca. 175–180°C depending on the ratio of D:L in the monomer mixture. Copolymers with glycolide are also widely applied due to the varied mechanical and degradation profile. Besides the broad application several factors may limit their use, such as high crystallinity resulting in (too) slow release, or acidic degradation products, i.e., carboxylic acids, which hamper cell growth in some cases.

Other polyesters, such as poly(hydroxy butyrate), which is produced by microbes, have so far not found many applications in nanotechnology.

Polypeptides/proteins

Proteins/peptides as building blocks for nanoparticles are obvious due to their degradability, usually non-toxicity and easy availability. Proteins are polymers from amino acids, produced by living organisms. They constitute tissues, have regulatory and transport properties, and catalyze metabolic reactions. So far, gelatin (a degradation product of collagen) and albumin have been used for the preparation of nanoparticles. The first commercialized protein nanoparticle-based product was albumin-bound paclitaxel (nab™-paclitaxel; Abraxane®) with a mean diameter of ca. 130 nm. It was approved by the FDA in 2005 for the treatment of breast cancer in patients who fail combination chemotherapy for metastases, or relapse within 6 months of adjuvant chemotherapy (Hawkins et al., 2008). Gelatin nanoparticles were proposed for drug delivery and, in combination with mineralized calcium phosphate, as bone substitute or bone-regrowth substrate (Balthasar et al., 2005; Kommareddy and Amiji, 2007; Ethirajan et al., 2008a,b; Gan et al., 2012; Khan and Schneider, 2013; Xu et al., 2014).

Lignin

Lignin is one of the most abundant renewable biopolymers. It is extracted from plants and represents approximately 15–30% of their total biomass besides cellulose as the major component. In spite of the huge amounts of lignin, which are readily available, lignin is normally considered as a non-preferred byproduct from the paper industry for example with over 30 mio t/a (Hatakeyama and Hatakeyama, 2010). A potential reason for considering lignin as a waste product is probably the very limited solubility of the native material and the complexity of the lignin structure with very broad molecular weight distributions and a random microstructure. Thus only 2% of lignin (mainly lignosulfonates) are applied in agricultural uses or other industries as binders, e.g., for animal feed pellets, bricks, ceramics, or road dust, dispersants for oil well drilling products, etc. (Lora and Glasser, 2002; Calvo-Flores and Dobado, 2010). Lignin is a highly branched polyphenolic polyether, with the main structural elements being three “monomeric units,” i.e., 4-hydroxyphenyl, guaiacyl, and syringyl derivatives, which are connected via aromatic and aliphatic ether bonds that build up a hyperbranched, i.e., irregularly branched polymer (Calvo-Flores and Dobado, 2010). Lignin is highly functional and carries both phenolic and aliphatic hydroxyl groups that can be used for further modification or polymerization. Several publications deal with the use of lignin in materials science, however only very few example are present that use lignin in nanoparticle formulations. Recently, lignin was doped with multi-walled carbon nanotubes and used as a macromonomer in a step-growth polymerization with toluene-2,4-diisocyanate (TDI) terminated poly(propylene glycol) for chemical sensoring applications (Faria et al., 2012). In addition, the hydroxyl groups of lignin films were modified with PNIPAM through ATRP under aqueous conditions to prepare ion-responsive nanofibers (Gao et al., 2012). We recently developed a straightforward strategy to generate hollow nanocapsules by interfacial polyaddition of lignin with TDI in an inverse miniemulsion. Lignin derivatives were dissolved in water and dispersed in organic solvent. Upon addition of TDI a polyaddition reaction with lignins' hydroxyl groups occurred at the droplet surface (Figure 4). By this approach hydrophilic substances can be incorporated into biodegradable lignin nanocontainers (Yiamsawas et al., 2014).

Figure 4.

Figure 4

Schematic representation for the preparation of lignin nanocapsules (image taken from Yiamsawas et al., 2014 - Published by The Royal Society of Chemistry).

Biogenic monomers

Amino acids

Amino acids are ubiquitous in nature as they are the monomeric units of proteins. Although recent studies describe the presence and importance of α-D-amino acids in proteins, the predominant natural form is the L-enantiomer. In addition to the proteinogenic amino acids, chemical functionality can easily be synthetically introduced into amino acids offering an extremely wide variety of possible applications. Amino acids are typically commercially available with fluorenylmethoxycarbonyl (Fmoc) or t-butoxycarbonyl (Boc) protected amino groups. In these forms they are suitable for controlled solid phase peptide synthesis. Peptides are sequentially constructed on a resin, offering structural and chemical control over the generated peptides. The obtained peptides can be used for pharmaceutical purposes, but also as structural motif in peptide polymer conjugates, as intermolecular and intramolecular interactions can be tuned by the peptide sequence. This determines the peptide structure and can eventually control the self-assembly behavior of peptide-polymer conjugates (Gauthier and Klok, 2008; Lutz and Börner, 2008; Krishna and Kiick, 2010). Introduced in nanoparticulate systems, they were used as cleavage site for release of encapsulated materials, but also for the recognition and optical detection of enzymes (Maier et al., 2011; Andrieu et al., 2012; Fuchs et al., 2013).

From polysaccharides

Polysaccharides can also serve as raw materials for the generation of fine chemicals, such as monomers for polymerization. Examples are bio-ethanol, which can be converted to ethylene glycol for polyaddition (PET) (Jang et al., 2012), or furan-based systems (Gandini and Belgacem, 1997; Gandini, 2008, 2011; Pranger and Tannenbaum, 2008; Gandini et al., 2009).

From triglycerides

Phospholipid vesicles, i.e., liposomes, have found increasing attention as nano-drug carriers since several decades. Additionally, oils and fatty acids derived from plants are currently discussed as versatile sources for the preparation of different products, including polymers and polymeric nanoparticles (Biermann et al., 2011). Since the beginning of the 1990s solid lipid nanoparticles (SLN) have been discussed as alternatives to synthetic polymer particles, due to their good biocompatibility, large-scale production and cost-effective formulation. The use of lipid pellets was already known for oral drug delivery, e.g., Mucosolvan(R) retard capsules, which was followed by lipid microparticles made by spray congealing (Eldem et al., 1991) and nanoparticles from microemulsion (Schwarz et al., 1994). A typical argument as an advantage of SLNs over polymeric nanoparticles is that they can be produced by high pressure homogenization identical to conventional oil in water emulsions (Müller et al., 2000), a process, which can be easily conducted industrially on large scale. Loading capacities are reported for several drugs and vary strongly with drug administered from a few percent for retinol (Westesen et al., 1997) for example up to 50% for ubidecarenone (i.e., Coenzym Q10) which is mainly related to the solubility of the drug in the lipid (Jenning et al., 2000). This loading capacity is also reflected in the drug release, which is often found as a burst release. Some examples present a release up to several weeks (5–7 weeks) by variation of the lipid matrix, surfactant concentration and production parameters (such as temperature) (Zur Mühlen and Mehnert, 1998).

Fatty acids can be derived from vegetable oils by hydrolysis (Mutlu and Meier, 2010; De Lima et al., 2013). They have been intensively studied for the use as building blocks in polymer science and derivatized to a variety of functional monomers. Recently, metathesis polymerization and used to prepare nanoparticles by miniemulsion. A strong dependence on the nature of the catalyst and surfactant was found; however the removal of Ru-based catalysts may be challenging in such systems (Cardoso et al., 2014). Also the encapsulation of several vegetable oils by emulsion techniques has been investigated (Cardoso et al., 2013). Jojoba and andiroba oil were encapsulated into polymeric nanostructures by miniemulsion polymerization. The effects of the addition of different hydrophilic monomers such as acrylic or methacrylic acid with the oils being co-stabilizers were evaluated. The formation of hollow (oil-filled) nanocapsules was investigated. Fatty acids were also used to prepare nanoparticles from protein-fatty acid ionic, i.e., salt, complexes (Yoo et al., 2001). Lysozyme was modified with hydrophobic fatty acid salt, i.e., sodium oleate, via ionic binding between the anionic carboxylate and the basic amino groups in lysozyme. The lysozyme-oleate complex dissolved in an organic solvent exhibited much higher conformational stability at elevated temperature than free lysozyme in the same solvent. The complex was formulated into biodegradable nanoparticles by a spontaneous emulsion and solvent diffusion method. The resultant formulation showed near 100% encapsulation efficiency of lysozyme within nanoparticles with <100 nm in diameter with a narrow size distribution. These biodegradable nanoparticles showed efficient encapsulation of proteins which are potentially useful for oral protein delivery including mucosal vaccination.

Others

Glycolipids are complex materials that can be produced by fermentation by yeast (such as Candida bombicola) from a mixture of carbohydrates and lipids. One class, the so called sophorolipids can be produced by fermentation of C. bombicola on glucose/oleic acid mixtures resulting in a mixture of several components including lactonic and acidic forms. Natural sophorolipids and selected derivatives are currently discussed for surfactants, emulsifiers, and therapeutic agents (antibacterial, antifungal, septic shock, anticancer, etc.) (Guilmanov et al., 2002; Zini et al., 2008). They have been polymerized via various polymerization techniques such as ring-opening metathesis polymerization and represents a promising class of materials for future development of drug-delivery vehicles for example.

Other plant derived chemicals as, e.g., terpenes have also been proposed for application in polymer science (Wilbon et al., 2013).

Preparation techniques

Nanoparticles can be formulated by basically three ways: (1) the monomer is polymerized during the preparation process to eventually form a nanoparticulate system, (2) an insoluble polymer is subjected to a physical process resulting in nanoparticles, (3) a soluble polymer is cross-linked in a suitable way. (1) Comprises classic or emulsifier free emulsion polymerization, miniemulsion polymerization and microemulsion polymerization, dispersion polymerization usually leads to microspheres. (2) Comprises (mini)emulsion solvent evaporation, emulsion solvent shifting or nanoprecipitation (Ouzo-effect). (3) Describes the formation of nanogels or crosslinked polymeric particles.

Nanoprecipitation/Ouzo-effect

Several terms can be found in the literature for the process, where a solution of an organic compound in a water miscible organic solvent is mixed with an excess of water and nanoparticles are generated by a phase separation process (Figure 5). Most widely used are the terms: nanoprecipitation, solvent shifting, or “Ouzo-effect” (Thioune et al., 1997; Vitale and Katz, 2003; Ganachaud and Katz, 2005; Hornig et al., 2009; Schubert et al., 2011; Aschenbrenner et al., 2013).

Figure 5.

Figure 5

Schematic representation of the polymeric Ouzo-effect. A polymeric solution is added to water. Nanophaseseparation leads to polymeric nanoparticles.

This phenomenon is well known from alcoholic beverages containing the oil of the anise seed, such as Ouzo or Pastis. These drinks are, chemically spoken, a solution of anethol (and some other components) in water/ethanol. When additional water is added to this solution, the solubility limit of anethol is passed and phase separation occurs. Interestingly, no macroscopic phases are initially generated. In contrast, submicron droplets with high stability are generated, resulting in the cloudy appearance of the drink after water addition. In other words, an aqueous dispersion of nanoparticles/droplets is generated without the necessity of additional energy input, which makes the process mild and cheap.

This process also finds application in the formulation of pigments (Horn and Rieger, 2001; Van Keuren et al., 2003, 2008; Chen et al., 2009), and has massively been used for the preparation of polymeric nanoparticles, especially polyester based, for pharmaceutical applications (Brick et al., 2003; Liebert et al., 2005; Miller, 2006; Hornig et al., 2009; Beck-Broichsitter et al., 2010; Mora-Huertas et al., 2010, 2011). Especially for the encapsulation of sensitive drugs, the absence of energy input is a great benefit.

Although a variety of solvent/polymer combinations have been evaluated, the mechanism of formation and stability is not completely elucidated. Despite the wide applicability and the ease of the system, the major drawback may be the low (around 1 wt%) solids contents which can be obtained (Brick et al., 2003; Vitale and Katz, 2003; Ganachaud and Katz, 2005; Aubry et al., 2009).

Emulsion based processes

Classic emulsion polymerization finds major application in the industrial production of (meth)acrylic and vinyl polymers via radical polymerization (Harkins, 1947). As the monomer has to diffuse through an aqueous phase to reach the place of polymerization, very hydrophobic monomers are difficult to process. Additionally, other polyreactions besides the free radical polymerization are difficult to handle. Preformed polymers cannot be formulated to nanoparticles using the emulsion polymerization technique. In contrast to the above mentioned phase separation stable preformed emulsions can be used as templates or enclosed reaction vessels of the dimensions of only few microns or several hundreds of nanometers for polyreactions or phase separation processes.

The stability of droplets in emulsions is governed by two processes: First, droplets fuse by collision and coalescence, and second, droplets degrade by diffusion (Ostwald Ripening). Coalescence can be controlled by the addition of surfactants to the emulsions. These create an electrostatic or steric barrier around the droplets, creating a repulsive force between the droplets. Ostwald Ripening is caused by the imbalance of Laplace pressures between droplets of different sizes. Higher curvature leads to higher Laplace pressure, forcing the contents of smaller droplets to diffuse into larger droplets. This can be counteracted by an as-narrow-as-possible droplet size distribution, and by the addition of a so-called costabilizer to the droplets. The presence of this costabilizer, which is a component with a very low solubitiy in the continuous phase, creates an osmotic pressure, opposite to the Laplace pressure. Consequently, diffusion is limited. Such systems are typically referred to as miniemulsions. The droplets stabilized in this manner can be used for various polyreactions and physical processes for nanoparticle formulation (Figure 6).

Figure 6.

Figure 6

Schematic representation of miniemulsion polymerization. Stable droplets in the range of few hundreds of nanometers are generated by the addition of a costabilizer (light green) and homogenization by ultrasound. The monomer droplets act as nanoreactors.

The stability of the droplets in miniemulsions can be used in several ways for the formation of nanoparticluate systems. Depending on the formulation technique, nanoparticles, nanocapsules, or nanogels can be created. Detailed reviews about the mechanism and the preparative possibilities have recently been published (Landfester et al., 1999a,b; Landfester, 2000, 2009; Asua, 2002, 2004; Schork et al., 2005; Crespy and Landfester, 2010; Landfester and Weiss, 2010; Weiss and Landfester, 2010).

Emulsion/solvent evaporation

In contrast to the above mentioned technique of nanoprecipitation, where phase separation for the formation of nanoparticles is induced in the bulk of the solution, phase separation can also be induced in droplets (Figure 7). Such is typically achieved by dispersing a polymer solution in a surfactant solution (typically aqueous) to form stable droplets. Either the polymer is precipitated by a water soluble organic solvent, diffusing from the droplet to the aqueous phase or by evaporating the solvent from the droplets (Mora-Huertas et al., 2011; Staff et al., 2013). Both lead to nucleation of the solid polymer, which starts at the droplet/solvent interface (Anton et al., 2008). As the solvent from the droplets is removed through the continuous phase, the miscibility of the solvents is crucial for evaporation and consequently for the (nano)particle formation. Solvent, temperature, pressure, and stirring speed are parameters which need to be controlled. Eventually, when the entire solvent has been removed, solid polymeric particles-stabilized by the surfactant which was initially added for stabilizing the droplets-form a stable dispersion.

Figure 7.

Figure 7

Schematic representation of the solvent evaporation process. A polymer solution is formulated as a surfactant stabilized emulsion. Subsequently the solvent is evaporated resulting in polymeric nanoparticles.

The process is conceptually easy and is principally suitable for all polymers, for which a good solvent can be found. Furthermore, the process is quite fast (few hours) and, in contrast to polymerization techniques, no residual monomer or initiator can be found in the dispersion. Drawbacks are mainly the broad particle size distribution, the low solids contents (few %) and residual surfactants. Concentrating and cleaning may overcome the latter both issues; they are however, time consuming discontinuous steps, which may prevent large scale application.

The use of not only one dissolved component in the dispersed phase reveals another exciting topic in this area. Depending of the wetting properties (interfacial energies) (Torza and Mason, 1970) of the dissolved components, the phase separation can be directed in such a way, that complex particle morphologies can be generated. Given enough time for complete phase separation, the morphology adopted presents a minimum of the Gibbs Free Enthalpy. These ideal equilibrium morphologies are core-shell, partially engulfed (snowman-like), and separated. In real systems, several factors such as the viscosity of the solution, the temperature, and the amount of surfactant, which influences interfacial energies, determine the final morphology of the particle. This can be one of the ideal morphologies, capsules if one component is liquid, but also multi-compartment structures and other kinetically controlled structures. A review about the features, the mechanism and the scope of the emulsion solvent evaporation process was recently published (Staff et al., 2013).

Emulsion/polyreactions

In the classic emulsion polymerization process, acrylic or vinylic monomers are dispersed in an aqueous surfactant solution by mechanical stirring. A water-soluble initiator for free radical polymerization is also added to the system. The surfactant concentration is higher than the critical micelle concentration (cmc). Polymerization is initiated in the aqueous phase, leading to water-insoluble oligomers, entering micelles containing the monomer. Here, polymerization is maintained, as further monomer is diffusing through the aqueous phase to the locus of polymerization (Figure 8). A modification is the so called soap-free emulsion polymerization (Goodwin et al., 1974). Here, the monomer is dispersed in an aqueous solution of initiator, which is typically a peroxodisulfate. Thus, polymerization is also initiated in the aqueous phase. The sulfate terminated oligomers act as surfactants, generating micelles, which then act as locus for polymerization. Eventually, polymeric particles of few hundreds of nanometers or smaller are generated. To initiate polymerization and sustain diffusion in a sufficient way, a certain water solubility of the monomers is required for both techniques. Although there is a report about polycondenstation in emulsion (Jönsson et al., 2013), leading to polyester particles, classic emulsion polymerization was mainly found to be suitable for free radical polymerization of sufficiently water-soluble acrylic or vinylic monomers.

Figure 8.

Figure 8

Schematic representation of classic emulsion polymerization.

In addition to microemulsion polymerization (Pavel, 2004; McClements, 2012) where aqueous solutions with very high surfactant concentration and additional co-surfactant (medium chain alcohol) is used (Figure 9), miniemulsions have shown to be a versatile platform for a variety of polyreactions (Crespy and Landfester, 2010, 2011).

Figure 9.

Figure 9

Schematic representation of microemulsion polymerization. Radical polymerization in very highly concentrated surfactant/co-surfactant solution leads to ultrasmall polymeric nanoparticles.

The above described features of miniemulsions allow among others conducting free radical polymerization of “normal” monomers and very hydrophobic monomers, even fluorinated monomers (Landfester et al., 2002), controlled radical polymerization (Bombalski et al., 2007; Esteves et al., 2007; Oh et al., 2007; Siegwart et al., 2009), anionic (Limouzin et al., 2003; Weiss et al., 2007a,b) and cationic polymerization (Cauvin and Ganachaud, 2004), catalytic polymerization (Cardoso et al., 2014; Malzahn et al., 2014b), as well as polyaddition and polycondesation reactions (Landfester et al., 2000; Tiarks et al., 2001; Barrère and Landfester, 2003). Each of these reactions can be used for the preparation of aqueous dispersions of polymeric nanoparticles. The major benefit of emulsion polymerization techniques is clearly the high achievable solid content, and the fact that this technique is already established in industry.

Emulsion/interfacial reactions/crosslinking

Polymerization can be conducted at interfaces-a very famous example is the “nylon rope trick.” Two immiscible solutions are overlaid, one containing a diamine the other one a diacid chloride. The product of the polycondensation, which can only proceed at the interface, i.e., a Schotten–Baumann reaction, can be drawn out of the biphasic system to produce a nylon thread. Translating such a system to the nanoscale can be used for creating a polymeric shell or membrane at the interface of a droplet in an emulsion. Aiming at nanocapsules with aqueous core, this classic reaction is not suitable, as the diacid chloride reacts to the unreactive diacid, upon contact with water which is a “dead end” and cannot participate in polymerization. Besides a very special monomer pair (hydrophilic vinyl ether and hydrophobic maleates) (Scott et al., 2005; Wu et al., 2006) for strictly alternating radical polymerization and the metathesis polymerization of acrylated dextran and unsaturated organophosphates (Malzahn et al., 2014b), mainly polyaddition reactions of a polyol or a polyamine with diisocyanates to generate polyurethane or polyurea are reported (Crespy et al., 2006). An aqueous solution of the water soluble component, such as low molecular compounds (Paiphansiri et al., 2009), polysaccharides (Crespy et al., 2006; Baier et al., 2012, 2013), or peptides (Andrieu et al., 2012), is dispersed in a solution of a surfactant in an inert solvent, typically a hydrocarbon, such as cyclohexane or isooctane. The other reactive component, e.g., toluene diisocyanate is added to the mixture, diffuses to the droplets and reacts at the interface with the alcohol or amine comonomer, or with water (Figure 10). The reaction with water generates a diamine, which can also act as comonomer and, in contrast to the diacid chloride, is not lost for polymer generation.

Figure 10.

Figure 10

Schematic representation of interfacial reactions in inverse emulsion. One monomer (purple) is provided in the aqueous droplets, the other one (light green) is added, dissolved in solvent. The reaction leads to a polymeric shell enclosing the water droplets.

If each monomer is insoluble in the other solvent, the reaction proceeds only at the interface. If the organo-soluble monomer shows certain solubility in the dispersed phase, polymerization can also proceed in the droplet. Once the molecular weight is high enough the polymer can become insoluble and precipitate at the interface. Thus, changing the quality of the solvent can be used for tuning the morphology from particle to capsule (Andrieu et al., 2012).

Creating droplets of a preformed functional polymer and adding a crosslinker can be used for the preparation of highly crosslinked organic nanoparticles or nano-scaled hydrogels (Maier et al., 2011; Klinger et al., 2012; Malzahn et al., 2014a).

Applications

The benefits of polymers from renewable resources are at the moment probably most prominent in applications in biomedicine. As outlined above, one of the major benefits of such systems is biocompatibility and the specific biochemical (enzymatic) or chemical (hydrolytic) degradation, which are of great importance, when such a system is proposed for application in living organisms. In addition to the use of proteins, especially gelatin, for the formulation of nanoparticles, the most of the relevant systems found in literature are based on polysaccharides and polyesters, especially poly(lactic acid). Indeed, besides commercially available polystyrene beads, nanoparticles made from poly(lactic acid) or derivatives are the most used polymeric nanoparticulate systems in biomedicine. Only part of the huge number of publications can be accounted for in this section. We hope to give an idea about the possibilities and refer the reader to comprehensive reviews about nanoparticles for biomedical applications.

Polysaccharides

As polysaccharides are typically hydrophilic and water soluble, formulating these polymers as nanoparticles in aqueous dispersion requires either hydrophobization prior to formulation, or crosslinking the polymer to form nanoscaled hydrogels. When the crosslinking reaction is conducted at the interface of a droplet, nanocapsules with liquid core can be generated (see above). Typically, the crosslinking with hydrophobic agents leads to impermeable shells. If the crosslinking reaction is conducted in a droplet containing the polysaccharide, nanogels are created. Rather recent reviews by Janes et al. (2001), Prabaharan et al. (Prabaharan and Mano, 2005), and Liu et al. (2008) describe many polysaccharide nanoparticle carriers in detail with respect to synthesis and applications. Herein, the fundamental and the most recent reports on nanoparticle preparation based on polysaccharides are addressed. Hydroxy ethyl starch (HES) based on natural starch, which is modified with ethylene glycol units, has proven to exhibit a stealth effect similar to PEG (see below, polyesters). The reduced protein adsorption of HES was already proven by several pharmaceuticals that are modified with it (Noga et al., 2012; Liebner et al., 2014). As a typical cross-linker for polysaccharides in early reports glutaraldehyde was frequently applied, e.g., for chitosan-based nanoparticles (Zhi et al., 2005), however the toxicity of glutaraldehyde limits its application in drug delivery as residues are difficult to remove from the crosslinked particles but may leak out during application. A more promising approach was established by the use of water-soluble carbodiimides, condensing the polysaccharide with natural di- or tricarboxylic acids, such as succinic acid, malic acid, tartaric acid, and citric acid. This condensation reaction was very efficient for chitosan particles as the reaction product is an amide. Such nanoparticles were stable in aqueous media at low pH, neutral, and mild alkaline conditions. In the swollen state, the average size of the particles was in the range of 270–370 nm depending on the pH (Bodnar et al., 2005). A convenient way to prepare nanocapsule structures, i.e., an aqueous liquid core, surrounded by a polysaccharide based shell, uses the OH-groups of polysaccharides for crosslinking with di-isocyanates at the interface of an aqueous droplet in an inverse emulsion. With the procedure described above, stable or degradable capsules were created. Dextran, hydroxyethyl starch, or hyaluronic acid was used and typically crosslinked with toluenediisocyanate. Baier et al. recently reported hyaluronic acid based nanocapsules containing an antibacerial agent. In the presence of bacteria (Staphylococcus aureus and Escherichia coli), which secrete hyaluronidase, an enzyme degrading hyaluronic acid, the capsules were opened and the bactericidal agent released, resulting in an inhibition in bacterial growth (Baier et al., 2013). The hydroxyl groups of polysaccharides can be transformed into many different reactive groups in order to use them for a subsequent polymerization/cross-linking step in a dispersed medium. Acrylation or Methacrylation are typical ways for the introduction of polymerizable groups, which additionally alter the solubility profile of the polysaccharide and allow their dispersion with an organic solvent in water or -if only a few crosslinking units are attached- in an inverse system, i.e., water in oil. We recently prepared hollow nanocapsules based on acrylated dextran which was crosslinked via olefin cross metathesis at the interface of water droplets in an organic continuous phase containing a diolefin phosphate as the comonomer. The olefin-cross metathesis was tailored to the interface of a miniemulsion for the design of novel fully degradable polysaccharide-co-polyphosphate nanoparticles. Dextran was modified with acrylate side groups which reacted at the water-oil-interface with hydrophobic diolefin phosphates to generate hollow nanocapsules. The Ru-catalyst remained in the organic continuous phase making a purification to obtain metal-free nanocapsules feasible (Malzahn et al., 2014b). Hydrophobically modified polysaccharides, e.g., by esterification, have been used for the preparation of water dispersible nanoparticles, typically by nanoprecipitation processes (Liebert et al., 2005; Hornig and Heinze, 2007, 2008; Hornig et al., 2008). The possibility for encapsulating small molecules was shown and confirmed by fluorescence correlation spectroscopy (Aschenbrenner et al., 2013).

Polyesters

As mentioned above polyesters are typically hydrophobic polymers which are degraded hydrolytically and are well tolerated by biological systems. Most of the work found in literature uses poly(lactic acid) “polylactide,” and copolymers with glycolic acid, PEG, or polysaccharides. Nanoparticles from poly(ε-caprolactone) are also reported. Typically, the material is used in its polymeric state. Thus, phase separation techniques for the generation of nanoparticles or nanopcapsules are mostly used. Hydrophobic and hydrophilic fluorophores (Bourges, 2003; Musyanovych et al., 2008), or drugs were encapsulated in pure PLA or in more complex copolymers (Niwa et al., 1993; Jeong et al., 2006a,b; Beck-Broichsitter et al., 2010). Capsules with diclofenac dissolved in an oil core were reported by Guterres et al. (1995) prepared with the nanoprecipitation technique. The preparation techniques also allow the protection of large biomolecules, as plasmid DNA (Perez et al., 2001) and proteins (Pillay et al., 2013; Zaric et al., 2013) as well as the encapsulation of hydrophobized magnetic iron oxides in PLA based nanoparticles. Using the emulsion/solvent evaporation technique, Urban et al. (2009) prepared poly-L-lactic acid (PLLA) nanoparticles of around 100 nm with almost 40 wt% of iron oxide. Encapsulation did not alter the magnetic properties of the iron oxide. Larger particles of 300 nm to 3 μm containing iron oxide were used by Xu et al. (2012) for tracking mesenchymal stem cells with MRI for almost 1 month. Cell functions and properties were not disturbed by the presence of the particles, allowing long term tracking, e.g., of cell migration. Nanoparticles prepared from hydrophobic polyesters are usually readily uptaken by cells via endocytosis (Mailander and Landfester, 2009). If the material is released from the endosome or partly degraded in it, an efficient drug delivery is observed. A typical drawback for all nanoparticles is the adsorption of plasma proteins after the injection in a living organism, resulting in an altered cell uptake or faster degradation of the nanoparticles before reaching the target site (Torchilin and Trubetskoy, 1995; Sahil et al., 1997; Owens and Peppas, 2006). To overcome this problem many particles are modified with poly(ethylene glycol) (PEG), which reduces the amount of adsorbed protein due to the so called “stealth effect,” which increases blood half life time by several orders of magnitude. The so called “PEGylation” is well-known for nanoparticles or molecularly dissolved drugs as the highly hydrated polyether reduces protein adsorption dramatically, (Bazile et al., 1995; Torchilin and Trubetskoy, 1995; Peracchia et al., 1999a,b; Andrieux and Couvreur, 2009) however, PEG is not degraded in vivo making a search for degradable alternatives in combination with degradable drug carriers necessary (Liebner et al., 2014) (see polysaccharides). Encapsulated material can either be released by diffusion from the polymeric matrix of the nanoparticles, and seems to depend on several factors as the preparation conditions, and the solubility of the drug in the dispersion medium. The reports range from few minutes to several days (Bourges, 2003; Pillay et al., 2013). The degradation of the polymeric matrix seems to play a minor role, only, as it is quite slow at physiological pH. In fact, diclofenac could be almost completely retained in PDLA for 8 months (Guterres et al., 1995). Control of the degradation properties was achieved by using graft copolymers, consisting of a polysaccharide backbone and grafted PLA (Nouvel et al., 2009) or PLGA chains. Polysaccharide specific enzymes degraded the backbone leading to decomposition of the whole nanostructure, leading to faster release than in the absence of the enzyme (Jeong et al., 2006a,b). Zaric et al. report a delivery system based on a combination of microneedles and antigen loaded PLGA nanoparticles. Microneedles from quickly degrading poly(methylvinylether-co-maleic anhydride) are used to deliver PLGA nanoparticles loaded with ovalbumin as model antigen. Encapsulation increases antigen stability in the microneedles and facilitates the targeting and activation of dendritic cells in the skin, opening up a promising route for vaccination (Zaric et al., 2013). Another, so far neglected, class of polyesters found recently more attention, namely polyesters based on phosphoric acid. Similar to DNA or RNA, these materials are connected by main-chain phosphates that are typically derived from phosphorus oxychloride but can also be made from natural occurring sodium phosphate by enzymatic esterification. Several synthesis strategies have been reported ranging from classical polycondensation, via anionic ring-opening polymerization to metathesis polymerization. Moreover, the materials have been investigated in various emulsion and micellar approaches, also in combination with polyesters such as poly lactide or DNA in cation/anion complexes for gene delivery (Mao and Leong, 2005; Zhang et al., 2012; Shen et al., 2013; Steinbach et al., 2013; Alexandrino et al., 2014; Baier et al., 2014).

Conclusion and outlook

The properties of nanoparticles from renewable resources are currently mainly exploited in biomedical sciences. Specific or unspecific degradation of the polymeric matrix is used for sustained release of encapsulated drugs or as probe for specific environments, e.g., the presence of enzymes or pH regimes. Despite all benefits and promising results, most of these applications, however, are far from being suitable for the industrial scale or a market-ready product. Environmental benignity does not play a major role here, as the prospective quantities are relatively low. This is probably due to the still low costs and established procedures for common vinyl monomers, etc., which are applied in industry today. Furthermore, the structural variety of many natural polymers makes their selective application challenging, broad molecular weight distributions, many different electrophilic and nucleophilic groups-sometimes in the same material- make their chemical modification and further postmodification more difficult compared to fully synthetic polymers. Additionally, the solubility profiles are usually different compared to industrial products [they dissolve in water (proteins, saccharides) or are hardly soluble at all (lignin)] making selective chemistry challenging as all other components must tolerate the aqueous conditions for example.

A prospective large scale application for polymeric nanoparticles from renewable resources may be found as major constituent of paints. For this application, the performance of the polymers has to match these of synthetic polymers and a suitable formulation technique has to be found. For these reasons, monomers derived from plant oils and formulated in conventional, emulsion polymerization based processes are probably most promising, as raw materials are readily available and polymerization techniques are established and allow the generation of dispersions with high solids contents.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Alexandrino E. M., Ritz S., Marsico F., Baier G., Mailander V., Landfester K., et al. (2014). Paclitaxel-loaded polyphosphate nanoparticles: a potential strategy for bone cancer treatment. J. Mater. Chem. B 2, 1298–1306 10.1039/c3tb21295e [DOI] [PubMed] [Google Scholar]
  2. Andrieu J., Kotman N., Maier M., Mailänder V., Strauss W. S. L., Weiss C. K., et al. (2012). Live monitoring of cargo release from peptide-based hybrid nanocapsules induced by enzyme cleavage. Macromol. Rapid Commun. 33, 248–253 10.1002/marc.201100729 [DOI] [PubMed] [Google Scholar]
  3. Andrieux K., Couvreur P. (2009). Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 463–474 10.1002/wnan.5 [DOI] [PubMed] [Google Scholar]
  4. Anton N., Benoit J.-P., Saulnier P. (2008). Design and production of nanoparticles formulated from nano-emulsion templates—a review. J. Control. Release 128, 185–199 10.1016/j.jconrel.2008.02.007 [DOI] [PubMed] [Google Scholar]
  5. Aschenbrenner E., Bley K., Koynov K., Makowski M., Kappl M., Landfester K., et al. (2013). Using the polymeric ouzo effect for the preparation of polysaccharide-based nanoparticles. Langmuir 29, 8845–8855 10.1021/la4017867 [DOI] [PubMed] [Google Scholar]
  6. Astruc D., Lu F., Aranzaes J. R. (2005). Nanoparticles as recyclable catalysts: the frontier between homogeneous and heterogeneous catalysis. Angew. Chem. Int. Ed. Engl. 44, 7852–7872 10.1002/anie.200500766 [DOI] [PubMed] [Google Scholar]
  7. Asua J. M. (2002). Miniemulsion polymerization. Prog. Polym. Sci. 27, 1283–1346 10.1016/S0079-6700(02)00010-2 [DOI] [Google Scholar]
  8. Asua J. M. (2004). Emulsion polymerization: from fundamental mechanisms to process developments. J. Polym. Sci. A Polym. Chem. 42, 1025–1041 10.1002/pola.11096 [DOI] [Google Scholar]
  9. Aubry J., Ganachaud F., Addad J. P. C., Cabane B. (2009). Nanoprecipitation of polymethylmethacrylate by solvent shifting: 1. Boundaries. Langmuir 25, 1970–1979 10.1021/la803000e [DOI] [PubMed] [Google Scholar]
  10. Auvergne R., Caillol S., David G., Boutevin B., Pascault J.-P. (2014). Biobased thermosetting epoxy: present and future. Chem. Rev. 114, 1082–1115 10.1021/cr3001274 [DOI] [PubMed] [Google Scholar]
  11. Baier G., Baki A., Tomcin S., Mailänder V., Alexandrino E., Wurm F., et al. (2014). Stabilization of nanoparticles synthesized by miniemulsion polymerization using “green” amino-acid based surfactants. Macromol. Symp. 337, 9–17 10.1002/masy.201450301 [DOI] [Google Scholar]
  12. Baier G., Baumann D., Siebert J. M., Musyanovych A., Mailänder V., Landfester K. (2012). Suppressing unspecific cell uptake for targeted delivery using hydroxyethyl starch nanocapsules. Biomacromolecules 13, 2704–2715 10.1021/bm300653v [DOI] [PubMed] [Google Scholar]
  13. Baier G., Cavallaro A., Vasilev K., Mailänder V., Musyanovych A., Landfester K. (2013). Enzyme responsive hyaluronic acid nanocapsules containing polyhexanide and their exposure to bacteria to prevent infection. Biomacromolecules 14, 1103–1112 10.1021/bm302003m [DOI] [PubMed] [Google Scholar]
  14. Balthasar S., Michaelis K., Dinauer N., Von Briesen H., Kreuter J., Langer K. (2005). Preparation and characterization of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. Biomater 26, 2723–2732 10.1016/j.biomaterials.2004.07.047 [DOI] [PubMed] [Google Scholar]
  15. Barrère M., Landfester K. (2003). High molecular weight polyurethane and polymer hybrid particles in aqueous miniemulsion. Macromolecules 36, 5119–5125 10.1021/ma025981+ [DOI] [Google Scholar]
  16. Bazile D., Prud'homme C., Bassoullet M.-T., Marlard M., Spenlehauer G., Veillard M. (1995). Stealth me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 84, 493–498 10.1002/jps.2600840420 [DOI] [PubMed] [Google Scholar]
  17. Beck-Broichsitter M., Rytting E., Lebhardt T., Wang X. Y., Kissel T. (2010). Preparation of nanoparticles by solvent displacement for drug delivery: a shift in the “ouzo region” upon drug loading. Eur. J. Pharm. Sci. 41, 244–253 10.1016/j.ejps.2010.06.007 [DOI] [PubMed] [Google Scholar]
  18. Becker J., Trugler A., Jakab A., Hohenester U., Sonnichsen C. (2010). The optimal aspect ratio of gold nanorods for plasmonic bio-sensing. Plasmonics 5, 161–167 10.1007/s11468-010-9130-2 [DOI] [Google Scholar]
  19. Biermann U., Bornscheuer U., Meier M. A., Metzger J. O., Schäfer H. J. (2011). Oils and fats as renewable raw materials in chemistry. Angew. Chem. Int. Ed. Engl. 50, 3854–3871 10.1002/anie.201002767 [DOI] [PubMed] [Google Scholar]
  20. Bodnar M., Hartmann J. F., Borbely J. (2005). Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules 6, 2521–2527 10.1021/bm0502258 [DOI] [PubMed] [Google Scholar]
  21. Bombalski L., Min K., Dong H., Tang C., Matyjaszewski K. (2007). Preparation of well-defined hybrid materials by atrp in miniemulsion. Macromolecules 40, 7429–7432 10.1021/ma071408k [DOI] [Google Scholar]
  22. Bourges J. L. (2003). Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest. Ophthalmol. Vis. Sci. 44, 3562–3569 10.1167/iovs.02-1068 [DOI] [PubMed] [Google Scholar]
  23. Brick M. C., Palmer H. J., Whitesides T. H. (2003). Formation of colloidal dispersions of organic materials in aqueous media by solvent shifting. Langmuir 19, 6367–6380 10.1021/la034173o [DOI] [Google Scholar]
  24. Calvo-Flores F. G., Dobado J. A. (2010). Lignin as renewable raw material. ChemSusChem 3, 1227–1235 10.1002/cssc.201000157 [DOI] [PubMed] [Google Scholar]
  25. Cardoso P. B., Araújo P. H. H., Sayer C. (2013). Encapsulation of jojoba and andiroba oils by miniemulsion polymerization. effect on molar mass distribution. Macromol. Symp. 324, 114–123 10.1002/masy.201200075 [DOI] [Google Scholar]
  26. Cardoso P. B., Musyanovych A., Landfester K., Sayer C., De Araújo P. H. H., Meier M. A. R. (2014). ADMET reactions in miniemulsion. J. Polym. Sci. A Polym. Chem. 52, 1300–1305 10.1002/pola.27118 [DOI] [Google Scholar]
  27. Cauvin S., Ganachaud F. (2004). On the preparation and polymerization of p-methoxystyrene miniemulsions in the presence of excess ytterbium triflate. Macromol. Symp. 215, 179–190 10.1002/masy.200451115 [DOI] [Google Scholar]
  28. Chen Q., Schönherr H., Vancso G. J. (2009). Mechanical properties of block copolymer vesicle membranes by atomic force microscopy. Soft Matter 5, 4944 10.1039/b903110c [DOI] [Google Scholar]
  29. Crespy D., Landfester K. (2010). Miniemulsion polymerization as a versatile tool for the synthesis of functionalized polymers. Beilstein J. Org. Chem. 6, 1132–1148 10.3762/bjoc.6.130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Crespy D., Landfester K. (2011). Making dry fertile: a practical tour of non-aqueous emulsions and miniemulsions, their preparation and some applications. Soft Matter 7, 11054–11064 10.1039/c1sm06156a [DOI] [Google Scholar]
  31. Crespy D., Musyanovych A., Landfester K. (2006). Synthesis of polymer particles and nanocapsules stabilized with PEO/PPO containing polymerizable surfactants in miniemulsion. Colloid Polym. Sci. 284, 780–787 10.1007/s00396-005-1446-7 [DOI] [Google Scholar]
  32. Daniel M. C., Astruc D. (2004). Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 104, 293–346 10.1021/cr030698+ [DOI] [PubMed] [Google Scholar]
  33. De Lima A. P. D., Aschenbrenner E. M., Oliveira S. D. N., Doucet J.-B., Weiss C. K., Ziener U., et al. (2013). Towards regioselective enzymatic hydrolysis and glycerolysis of tricaprylin in miniemulsion and the direct preparation of polyurethane from the hydrolysis products. J. Mol. Catal. B Enzym. 98, 127–137 10.1016/j.molcatb.2013.10.013 [DOI] [Google Scholar]
  34. Eldem T., Speiser P., Hincal A. (1991). Optimization of spray-dried and -congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm. Res. 8, 47–54 10.1023/A:1015874121860 [DOI] [PubMed] [Google Scholar]
  35. Esteves A. C. C., Bombalski L., Trindade T., Matyjaszewski K., Barros-Timmons A. (2007). Polymer grafting from Cds quantum dots via AGET ATRP in miniemulsion. Small 3, 1230–1236 10.1002/smll.200600510 [DOI] [PubMed] [Google Scholar]
  36. Ethirajan A., Schoeller K., Musyanovych A., Ziener U., Landfester K. (2008a). Synthesis and optimization of gelatin nanoparticles using the miniemulsion process. Biomacromolecules 9, 2383–2389 10.1021/bm800377w [DOI] [PubMed] [Google Scholar]
  37. Ethirajan A., Ziener U., Chuvilin A., Kaiser U., Colfen H., Landfester K. (2008b). Biomimetic hydroxyapatite crystallization in gelatin nanoparticles synthesized using a miniemulsion process. Adv. Funct. Mater. 18, 2221–2227 10.1002/adfm.200800048 [DOI] [Google Scholar]
  38. Faria F. A. C., Evtuguin D. V., Rudnitskaya A., Gomes M. T. S. R., Oliveira J. A. B. P., Costa L. C. (2012). Lignin-based polyurethane doped with carbon nanotubes for sensor applications. Polym. Int. 61, 788–794 10.1002/pi.414023162814 [DOI] [Google Scholar]
  39. Fernandes E. M., Pires R. A., Mano J. F., Reis R. L. (2013). Bionanocomposites from lignocellulosic resources: properties, applications and future trends for their use in the biomedical field. Prog. Polym. Sci. 38, 1415–1441 10.1016/j.progpolymsci.2013.05.013 [DOI] [Google Scholar]
  40. Fuchs A. V., Kotman N., Andrieu J., Mailänder V., Weiss C. K., Landfester K. (2013). Enzyme cleavable nanoparticles from peptide based triblock copolymers. Nanoscale 5, 4829–4839 10.1039/c3nr00706e [DOI] [PubMed] [Google Scholar]
  41. Gan Z., Zhang T., Liu Y., Wu D. (2012). Temperature-triggered enzyme immobilization and release based on cross-linked gelatin nanoparticles. PLoS ONE 7:e47154 10.1371/journal.pone.0047154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ganachaud F., Katz J. L. (2005). Nanoparticles and nanocapsules created using the ouzo effect: spontaneous emulsification as an alternative to ultrasonic and high-shear devices. Chemphyschem 6, 209–216 10.1002/cphc.200400527 [DOI] [PubMed] [Google Scholar]
  43. Gandini A. (2008). Polymers from renewable resources: a challenge for the future of macromolecular materials. Macromolecules 41, 9491–9504 10.1021/ma801735u [DOI] [Google Scholar]
  44. Gandini A. (2011). The irruption of polymers from renewable resources on the scene of macromolecular science and technology. Green Chem. 13, 1061–1083 10.1039/c0gc00789g [DOI] [Google Scholar]
  45. Gandini A., Belgacem M. N. (1997). Furans in polymer chemistry. Prog. Polym. Sci. 22, 1203–1379 10.1016/S0079-6700(97)00004-X [DOI] [Google Scholar]
  46. Gandini A., Silvestre A. J. D., Neto C. P., Sousa A. F., Gomes M. (2009). The furan counterpart of poly(ethylene terephthalate): an alternative material based on renewable resources. J. Polym. Sci. A Polym. Chem. 47, 295–298 10.1002/pola.23130 [DOI] [Google Scholar]
  47. Gao G., Dallmeyer J. I., Kadla J. F. (2012). Synthesis of lignin nanofibers with ionic-responsive shells: water-expandable lignin-based nanofibrous mats. Biomacromolecules 13, 3602–3610 10.1021/bm301039f [DOI] [PubMed] [Google Scholar]
  48. Gauthier M. A., Klok H.-A. (2008). Peptide/protein-polymer conjugates: synthetic strategies and design concepts. Chem. Commun. 2591–2611 10.1039/b719689j [DOI] [PubMed] [Google Scholar]
  49. Good I. L., Kenoyer J. M., Meadow R. H. (2009). New evidence for early silk in the indus civilization. Archaeometry 51, 457–466 10.1111/j.1475-4754.2008.00454.x [DOI] [Google Scholar]
  50. Goodwin J. W., Hearn J., Ho C. C., Ottewill R. H. (1974). Studies on the preparation and characterisation of monodisperse polystyrene laticee. Colloid Polym. Sci. 252, 464–471 10.1007/BF0155475216229508 [DOI] [Google Scholar]
  51. Guilmanov V., Ballistreri A., Impallomeni G., Gross R. A. (2002). Oxygen transfer rate and sophorose lipid production by Candida bombicola. Biotechnol. Bioeng. 77, 489–494 10.1002/bit.10177 [DOI] [PubMed] [Google Scholar]
  52. Gupta A. P., Kumar V. (2007). New emerging trends in synthetic biodegradable polymers—polylactide: a critique. Eur. Polym. J. 43, 4053–4074 10.1016/j.eurpolymj.2007.06.045 [DOI] [Google Scholar]
  53. Guterres S. S., Fessi H., Barratt G., Devissaguet J. P., Puisieux F. (1995). Poly(DL-lactide) nanocapsules containing diclofenac: I. Formulation and stability study. Int. J. Pharm. 113, 57–63 10.1016/0378-5173(94)00177-7 [DOI] [Google Scholar]
  54. Harkins W. D. (1947). A general theory of the mechanism of emulsion polymerization1. J. Am. Chem. Soc. 69, 1428–1444 10.1021/ja01198a053 [DOI] [PubMed] [Google Scholar]
  55. Hatakeyama H., Hatakeyama T. (2010). Lignin, proteins, bioactive nanocomposites, in Biopolymers, eds. Abe A., Dusek K., Kobayashi S. (Berlin: Springer Verlag; ), 1–63 [Google Scholar]
  56. Hawkins M. J., Soon-Shiong P., Desai N. (2008). Protein nanoparticles as drug carriers in clinical medicine. Adv. Drug Deliv. Rev. 60, 876–885 10.1016/j.addr.2007.08.044 [DOI] [PubMed] [Google Scholar]
  57. Horn D., Rieger J. (2001). Organic nanoparticles in the aqueous phase—theory, experiment, and use. Angew. Chem.Int. Ed.Engl. 40, 4331–4361 [DOI] [PubMed] [Google Scholar]
  58. Hornig S., Biskup C., Gräfe A., Wotschadlo J., Liebert T., Mohr G. J., et al. (2008). Biocompatible fluorescent nanoparticles for pH-sensoring. Soft Matter 4, 1169–1172 10.1039/b800276b [DOI] [PubMed] [Google Scholar]
  59. Hornig S., Heinze T. (2007). Nanoscale structures of dextran esters. Carbohydr. Polym. 68, 280–286 10.1016/j.carbpol.2006.12.007 [DOI] [Google Scholar]
  60. Hornig S., Heinze T. (2008). Efficient approach to design stable water-dispersible nanoparticles of hydrophobic cellulose esters. Biomacromolecules 9, 1487–1492 10.1021/bm8000155 [DOI] [PubMed] [Google Scholar]
  61. Hornig S., Heinze T., Becer C. R., Schubert U. S. (2009). Synthetic polymeric nanoparticles by nanoprecipitation. J. Mater. Chem. 19, 3838–3840 10.1039/b906556n [DOI] [Google Scholar]
  62. Hosler D. (1999). Prehistoric polymers: rubber processing in ancient mesoamerica. Science 284, 1988–1991 10.1126/science.284.5422.1988 [DOI] [PubMed] [Google Scholar]
  63. Janes K. A., Calvo P., Alonso M. J. (2001). Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 47, 83–97 10.1016/S0169-409X(00)00123-X [DOI] [PubMed] [Google Scholar]
  64. Jang Y.-S., Kim B., Shin J. H., Choi Y. J., Choi S., Song C. W., et al. (2012). Bio-based production of C2–C6 platform chemicals. Biotechnol. Bioeng. 109, 2437–2459 10.1002/bit.24599 [DOI] [PubMed] [Google Scholar]
  65. Jenning V., Gysler A., Schäfer-Korting M., Gohla S. H. (2000). Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 49, 211–218 10.1016/S0939-6411(99)00075-2 [DOI] [PubMed] [Google Scholar]
  66. Jeong Y.-I., Choi K.-C., Song C.-E. (2006a). Doxorubicin release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran. Arch. Pharm. Res. 29, 712–719 10.1007/BF02968257 [DOI] [PubMed] [Google Scholar]
  67. Jeong Y.-I., Na H.-S., Oh J.-S., Choi K.-C., Song C.-E., Lee H.-C. (2006b). Adriamycin release from self-assembling nanospheres of poly(dl-lactide-co-glycolide)-grafted pullulan. Int. J. Pharm. 322, 154–160 10.1016/j.ijpharm.2006.05.020 [DOI] [PubMed] [Google Scholar]
  68. Jönsson J. B., Müllner M., Piculell L., Karlsson O. J. (2013). Emulsion condensation polymerization in dispersed aqueous media. interfacial reactions and nanoparticle formation. Macromolecules 46, 9104–9113 10.1021/ma401799g [DOI] [Google Scholar]
  69. Kamat P. V. (2007). Meeting the clean energy demand: nanostructure architectures for solar energy conversion. J. Phys. Chem. C 111, 2834–2860 10.1021/jp066952u [DOI] [Google Scholar]
  70. Kfoury G., Raquez J.-M., Hassouna F., Odent J., Toniazzo V., Ruch D., et al. (2013). Recent advances in high performance poly(lactide): from “green” plasticization to super-tough materials via (reactive) compounding. Front. Chem. 1:32 10.3389/fchem.2013.00032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Khan S. A., Schneider M. (2013). Improvement of nanoprecipitation technique for preparation of gelatin nanoparticles and potential macromolecular drug loading. Macromol. Biosci. 13, 455–463 10.1002/mabi.201200382 [DOI] [PubMed] [Google Scholar]
  72. Kim I.-Y., Seo S.-J., Moon H.-S., Yoo M.-K., Park I.-Y., Kim B.-C., et al. (2008). Chitosan and its derivatives for tissue engineering applications. Biotechnol. Adv. 26, 1–21 10.1016/j.biotechadv.2007.07.009 [DOI] [PubMed] [Google Scholar]
  73. Klinger D., Aschenbrenner E. M., Weiss C. K., Landfester K. (2012). Enzymatically degradable nanogels by inverse miniemulsion copolymerization of acrylamide with dextran methacrylates as crosslinkers. Polym. Chem. 3, 204–216 10.1039/c1py00415h [DOI] [Google Scholar]
  74. Kommareddy S., Amiji M. (2007). Poly(Ethylene Glycol)-Modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery. Nanomedicine 3, 32–42 10.1016/j.nano.2006.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Krishna O. D., Kiick K. L. (2010). Protein- and peptide-modified synthetic polymeric biomaterials. Biopolymers 94, 32–48 10.1002/bip.21333 [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Kvavadze E., Bar-Yosef O., Belfer-Cohen A., Boaretto E., Jakeli N., Matskevich Z., et al. (2009). 30,000-year-old wild flax fibers. Science 325, 1359–1359 10.1126/science.1175404 [DOI] [PubMed] [Google Scholar]
  77. Landfester K. (2000). Recent developments in miniemlsions—formation and stability mechanisms. Macromol. Symp. 150, 171–178 [DOI] [Google Scholar]
  78. Landfester K. (2009). Miniemulsion polymerization and the structure of polymer and hybrid nanoparticles13. Angew. Chem. Int. Ed. Engl. 48, 4488–4507 10.1002/anie.200900723 [DOI] [PubMed] [Google Scholar]
  79. Landfester K., Bechthold N., Tiarks F., Antonietti M. (1999a). Formulation and stability mechanisms of polymerizable miniemulsions. Macromolecules 32, 5222–5228 10.1021/ma990299+ [DOI] [Google Scholar]
  80. Landfester K., Bechthold N., Tiarks F., Antonietti M. (1999b). Miniemulsion polymerization with cationic and nonionic surfactants: a very efficient use of surfactants for heterophase polymerization. Macromolecules 32, 2679–2683 10.1021/ma9819438 [DOI] [Google Scholar]
  81. Landfester K., Rothe R., Antonietti M. (2002). Convenient synthesis of fluorinated latexes and core-shell structures by miniemulsion polymerization. Macromolecules 35, 1658–1662 10.1021/ma011608a [DOI] [Google Scholar]
  82. Landfester K., Tiarks F., Hentze H.-P., Antonietti M. (2000). Polyaddition in miniemulsions: a new route to polymer dispersions. Macromol. Chem. Phys. 201, 1–5 [DOI] [Google Scholar]
  83. Landfester K., Weiss C. K. (2010). Encapsulation by miniemulsion polymerization. Adv. Polym. Sci. 229, 1–49 10.1007/12_2009_43 [DOI] [Google Scholar]
  84. Liebert T., Hornig S., Hesse S., Heinze T. (2005). Nanoparticles on the basis of highly functionalized dextrans. J. Am. Chem. Soc. 127, 10484–10485 10.1021/ja052594h [DOI] [PubMed] [Google Scholar]
  85. Liebner R., Mathaes R., Meyer M., Hey T., Winter G., Besheer A. (2014). Protein HESylation for half-life extension: synthesis, characterization and pharmacokinetics of HESylated anakinra. Eur. J. Pharm. Biopharm. 87, 378–385 10.1016/j.ejpb.2014.03.010 [DOI] [PubMed] [Google Scholar]
  86. Limouzin C., Caviggia A., Ganachaud F., Hémery P. (2003). Anionic polymerization of n-butyl cyanoacrylate in emulsion and miniemulsion. Macromolecules 36, 667–674 10.1021/ma0257402 [DOI] [Google Scholar]
  87. Liu Z., Jiao Y., Wang Y., Zhou C., Zhang Z. (2008). Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv. Rev. 60, 1650–1662 10.1016/j.addr.2008.09.001 [DOI] [PubMed] [Google Scholar]
  88. Lligadas G., Ronda J. C., Galià M., Cádiz V. (2013). Renewable polymeric materials from vegetable oils: a perspective. Mater. Today 16, 337–343 10.1016/j.mattod.2013.08.016 [DOI] [Google Scholar]
  89. Lora J. H., Glasser W. G. (2002). Recent industrial applications of lignin: a sustainable alternative to nonrenewable materials. J. Polym. Environ. 10, 39–48 10.1023/A:1021070006895 [DOI] [Google Scholar]
  90. Luengo J. M., Garcí A. B., Sandoval A., Naharro G., Olivera E. A. R. (2003). Bioplastics from microorganisms. Curr. Opin. Microbiol. 6, 251–260 10.1016/S1369-5274(03)00040-7 [DOI] [PubMed] [Google Scholar]
  91. Lutz J.-F., Börner H. G. (2008). Modern trends in polymer bioconjugates design. Prog. Polym. Sci. 33, 1–39 10.1016/j.progpolymsci.2007.07.005 [DOI] [Google Scholar]
  92. Madhavan Nampoothiri K., Nair N. R., John R. P. (2010). An overview of the recent developments in polylactide (PLA) research. Bioresour. Technol. 101, 8493–8501 10.1016/j.biortech.2010.05.092 [DOI] [PubMed] [Google Scholar]
  93. Maier M., Kotman N., Friedrichs C., Andrieu J., Wagner M., Graf R., et al. (2011). Highly site specific, protease cleavable, hydrophobic peptide–polymer nanoparticles. Macromolecules 44, 6258–6267 10.1021/ma201149b [DOI] [Google Scholar]
  94. Mailander V., Landfester K. (2009). Interaction of nanoparticles with cells. Biomacromolecules 10, 2379–2400 10.1021/bm900266r [DOI] [PubMed] [Google Scholar]
  95. Malzahn K., Jamieson W. D., Dröge M., Mailänder V., Jenkins A. T. A., Weiss C. K., et al. (2014a). Advanced dextran based nanogels for fighting Staphylococcus aureus infections by sustained zinc release. J. Mater. Chem. B 2, 2175–2183 10.1039/c3tb21335h [DOI] [PubMed] [Google Scholar]
  96. Malzahn K., Marsico F., Koynov K., Landfester K., Weiss C. K., Wurm F. R. (2014b). Selective interfacial olefin cross metathesis for the preparation of hollow nanocapsules. ACS Macro Lett. 3, 40–43 10.1021/mz400578e [DOI] [PubMed] [Google Scholar]
  97. Mao H. Q., Leong K. W. (2005). Design of polyphosphoester-DNA nanoparticles for non-viral gene delivery, in Advances in Genetics, eds Leaf Huang M.-C. H., Ernst W. (San Diego, CA; London: Academic Press; ), 275–306 [DOI] [PubMed] [Google Scholar]
  98. McClements D. J. (2012). Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter 8, 1719 10.1039/c2sm06903b [DOI] [Google Scholar]
  99. Miao S., Wang P., Su Z., Zhang S. (2014). Vegetable-oil-based polymers as future polymeric biomaterials. Acta Biomater. 10, 1692–1704 10.1016/j.actbio.2013.08.040 [DOI] [PubMed] [Google Scholar]
  100. Miller C. A. (2006). Spontaneous emulsification: recent developments with emphasis on self-emulsification, in Emulsion and Emulsion Stability, Surfactant Science Series, Vol. 61, ed Sjöblom J. (Boca Raton, FL: CRC Press; Taylor & Francis; ). [Google Scholar]
  101. Montero de Espinosa L., Meier M. A. R. (2011). Plant oils: the perfect renewable resource for polymer science?! Eur. Polym. J. 47, 837–852 10.1016/j.eurpolymj.2010.11.020 [DOI] [Google Scholar]
  102. Mora-Huertas C. E., Fessi H., Elaissari A. (2010). Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 385, 113–142 10.1016/j.ijpharm.2009.10.018 [DOI] [PubMed] [Google Scholar]
  103. Mora-Huertas C. E., Fessi H., Elaissari A. (2011). Influence of process and formulation parameters on the formation of submicron particles by solvent displacement and emulsification-diffusion methods Critical comparison. Adv. Colloid Interface Sci. 163, 90–122 10.1016/j.cis.2011.02.005 [DOI] [PubMed] [Google Scholar]
  104. Mosiewicki M. A., Aranguren M. I. (2013). A short review on novel biocomposites based on plant oil precursors. Eur. Polym. J. 49, 1243–1256 10.1016/j.eurpolymj.2013.02.034 [DOI] [Google Scholar]
  105. Müller R. H., Mäder K., Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur. J. Pharm. Biopharm. 50, 161–177 10.1016/S0939-6411(00)00087-4 [DOI] [PubMed] [Google Scholar]
  106. Muñoz-Espí R., Weiss C. K., Landfester K. (2012). Inorganic nanoparticles prepared in miniemulsion. Curr. Opin. Colloid Interface Sci. 17, 212–224 10.1016/j.cocis.2012.04.002 [DOI] [Google Scholar]
  107. Musto P. (2013). Grand challenges in polymer chemistry: energy, environment, health. Front. Chem. 1:31 10.3389/fchem.2013.00031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Musyanovych A., Schmitz-Wienke J., Mailänder V., Walther P., Landfester K. (2008). Preparation of biodegradable polymer nanoparticles by miniemulsion technique and their cell interactions. Macromol. Biosci. 8, 127–139 10.1002/mabi.200700241 [DOI] [PubMed] [Google Scholar]
  109. Mutlu H., Meier M. A. R. (2010). Castor oil as a renewable resource for the chemical industry. Eur. J. Lipid Sci. Technol. 112, 10–30 10.1002/ejlt.200900138 [DOI] [Google Scholar]
  110. Na H. B., Song I. C., Hyeon T. (2009). Inorganic nanoparticles for MRI contrast agents. Adv. Mater. 21, 2133–2148 10.1002/adma.200802366 [DOI] [Google Scholar]
  111. Niwa T., Takeuchi H., Hino T., Kunou N., Kawashima Y. (1993). Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J. Control. Release 25, 89–98 10.1016/0168-3659(93)90097-O [DOI] [Google Scholar]
  112. Noga M., Edinger D., Rödl W., Wagner E., Winter G., Besheer A. (2012). Controlled shielding and deshielding of gene delivery polyplexes using hydroxyethyl starch (HES) and alpha-amylase. J. Control. Release 159, 92–103 10.1016/j.jconrel.2012.01.006 [DOI] [PubMed] [Google Scholar]
  113. Nouvel C., Raynaud J., Marie E., Dellacherie E., Six J. L., Durand A. (2009). Biodegradable nanoparticles made from polylactide-grafted dextran copolymers. J. Colloid Interface Sci. 330, 337–343 10.1016/j.jcis.2008.10.069 [DOI] [PubMed] [Google Scholar]
  114. Oh J. K., Siegwart D. J., Lee H. I., Sherwood G., Peteanu L., Hollinger J. O., et al. (2007). Biodegradable nanogels prepared by atom transfer radical polymerization as potential drug delivery carriers: synthesis, biodegradation, in vitro release, and bioconjugation. J. Am. Chem. Soc. 129, 5939–5945 10.1021/ja069150l [DOI] [PubMed] [Google Scholar]
  115. Owens D. E., III., Peppas N. A. (2006). Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307, 93–102 10.1016/j.ijpharm.2005.10.010 [DOI] [PubMed] [Google Scholar]
  116. Paiphansiri U., Dausend J., Musyanovych A., Mailänder V., Landfester K. (2009). Fluorescent polyurethane nanocapsules prepared via inverse miniemulsion: surface functionalization for use as biocarriers. Macromol. Biosci. 9, 575–584 10.1002/mabi.200800293 [DOI] [PubMed] [Google Scholar]
  117. Pavel F. M. (2004). Microemulsion polymerization. J. Disper. Sci. Technol. 25, 1–16 10.1081/DIS-120027662 [DOI] [Google Scholar]
  118. Peracchia M. T., Fattal E., Desmaële D., Besnard M., Noel J.-P., Gomis J. M., et al. (1999a). Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administratio and splenic targeting. J. Control. Release 60, 121–128 10.1016/S0168-3659(99)00063-2 [DOI] [PubMed] [Google Scholar]
  119. Peracchia M. T., Harnisch S., Pinto-Alphandary H., Gulik A., Dedieu J.-C., Desmaële D., et al. (1999b). Visualization of in vitro protein-rejecting properties of PEGylated stealth(R) polycyanoacrylate nanoparticles. Biomaterials 20, 1269–1275 10.1016/S0142-9612(99)00021-6 [DOI] [PubMed] [Google Scholar]
  120. Perez C., Sanchez A., Putnam D., Ting D., Langer R., Alonso M. J. (2001). Poly (lactic acid)-poly (ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J. Control. Release 75, 211–224 10.1016/S0168-3659(01)00397-2 [DOI] [PubMed] [Google Scholar]
  121. Pillay V., Tomar T., Kumar M., Kumar P., Singh H., Choonara Y. E. (2013). In vivo evaluation of a conjugated poly(lactide-ethylene glycol) nanoparticle depot formulation for prolonged insulin delivery in the diabetic rabbit model. Int. J. Nanomedicine. 8, 505–520 10.2147/IJN.S38011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Prabaharan M., Mano J. F. (2005). Chitosan-based particles as controlled drug delivery systems. Drug Deliv. 12, 41–57 10.1080/10717540590889781 [DOI] [PubMed] [Google Scholar]
  123. Pranger L., Tannenbaum R. (2008). Biobased nanocomposites prepared by in situ polymerization of furfuryl alcohol with cellulose whiskers or montmorillonite clay. Macromolecules 41, 8682–8687 10.1021/ma8020213 [DOI] [Google Scholar]
  124. Raquez J. M., Deléglise M., Lacrampe M. F., Krawczak P. (2010). Thermosetting (bio)materials derived from renewable resources: a critical review. Prog. Polym. Sci. 35, 487–509 10.1016/j.progpolymsci.2010.01.001 [DOI] [Google Scholar]
  125. Raquez J.-M., Habibi Y., Murariu M., Dubois P. (2013). Polylactide (PLA)-based nanocomposites. Prog. Polym. Sci. 38, 1504–1542 10.1016/j.progpolymsci.2013.05.014 [DOI] [Google Scholar]
  126. Sahil H., Tapon-Bretaudière J., Fischer A.-M., Sternberg C., Spenlehauer G., Verrecchia T., et al. (1997). Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system. Biomaterials 18, 281–288 10.1016/S0142-9612(96)00146-9 [DOI] [PubMed] [Google Scholar]
  127. Schork F. J., Luo Y., Smulders W., Russum J. P., Butté A., Fontenot K. (2005). Miniemulsion polymerization. Adv. Polym. Sci. 175, 129–255 10.1007/b100115 [DOI] [Google Scholar]
  128. Schubert S., Delaney J. J. T., Schubert U. S. (2011). Nanoprecipitation and nanoformulation of polymers: from history to powerful possibilities beyond poly(lactic acid). Soft Matter 7, 1581–1588 10.1039/c0sm00862a [DOI] [Google Scholar]
  129. Schwarz C., Mehnert W., Lucks J. S., Müller R. H. (1994). Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J. Control. Release 30, 83–96 10.1016/0168-3659(94)90047-7 [DOI] [Google Scholar]
  130. Scott C., Wu D., Ho C. C., Co C. C. (2005). Liquid-core capsules via interfacial polymerization: a free-radical analogy of the nylon rope trick. J. Am. Chem. Soc. 127, 4160–4161 10.1021/ja044532h [DOI] [PubMed] [Google Scholar]
  131. Sharma V., Kundu P. P. (2008). Condensation polymers from natural oils. Prog. Polym. Sci. 33, 1199–1215 10.1016/j.progpolymsci.2008.07.004 [DOI] [Google Scholar]
  132. Shen Y., Zhang S., Zhang F., Loftis A., Pavía-Sanders A., Zou J., et al. (2013). Polyphosphoester-based cationic nanoparticles serendipitously release integral biologically-active components to serve as novel degradable inducible nitric oxide synthase inhibitors. Adv. Mater. 25, 5609–5614 10.1002/adma.201302842 [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Siegwart D. J., Srinivasan A., Bencherif S. A., Karunanidhi A., Oh J. K., Vaidya S., et al. (2009). Cellular uptake of functional nanogels prepared by inverse miniemulsion atrp with encapsulated proteins, carbohydrates, and gold nanoparticles. Biomacromolecules 10, 2300–2309 10.1021/bm9004904 [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Staff R. H., Landfester K., Crespy D. (2013). Recent advances in the emulsion solvent evaporation technique for the preparation of nanoparticles and nanocapsules. Adv. Polym. Sci. 262, 329–344 10.1007/12_2013_233 [DOI] [Google Scholar]
  135. Steinbach T., Alexandrino E. M., Wurm F. R. (2013). Unsaturated poly(phosphoester)s via ring-opening metathesis polymerization. Polym. Chem. 4, 3800–3806 10.1039/c3py00437f [DOI] [Google Scholar]
  136. Thioune O., Fessi H., Devissaguet J. P., Puisieux F. (1997). Preparation of pseudolatex by nanoprecipitation: influence of the solvent nature on intrinsic viscosity and interaction constant. Int. J. Pharm. 146, 233–238 10.1016/S0378-5173(96)04830-2 [DOI] [Google Scholar]
  137. Tiarks F., Landfester K., Antonietti M. (2001). One-step preparation of polyurethane dispersions by miniemulsion polyaddition. J. Polym. Sci. A: Polym. Chem. 39, 2520–2524 10.1002/pola.1228 [DOI] [Google Scholar]
  138. Torchilin V. P., Trubetskoy V. S. (1995). Which polymers can make nanoparticulate drug carriers long-circulating? Adv. Drug Deliv. Rev. 16, 141–155 10.1016/0169-409X(95)00022-Y [DOI] [Google Scholar]
  139. Torza S., Mason S. G. (1970). Three-phase interactions in shear and electrical fields. J. Colloid Interface Sci. 33, 67–83 10.1016/0021-9797(70)90073-1 [DOI] [Google Scholar]
  140. Urban M., Musyanovych A., Landfester K. (2009). Fluorescent superparamagnetic polylactide nanoparticles by combination of miniemulsion and emulsion/solvent evaporation techniques. Macromol. Chem. Phys. 210, 961–970 10.1002/macp.200900071 [DOI] [Google Scholar]
  141. Vallet-Regi M., Balas F., Arcos D. (2007). Mesoporous materials for drug delivery. Angew. Chem. Int. Ed. Engl. 46, 7548–7558 10.1002/anie.200604488 [DOI] [PubMed] [Google Scholar]
  142. Van Keuren E., Bone A., Ma C. B. (2008). Phthalocyanine nanoparticle formation in supersaturated solutions. Langmuir 24, 6079–6084 10.1021/la800290s [DOI] [PubMed] [Google Scholar]
  143. Van Keuren E., Georgieva E., Durst M. (2003). Kinetics of the growth of anthracene nanoparticles. J. Disper. Sci. Technol. 24, 721–729 10.1081/DIS-120023819 [DOI] [Google Scholar]
  144. Vemula P. K., John G. (2008). Crops: a green approach toward self-assembled soft materials. Acc. Chem. Res. 41, 769–782 10.1021/ar7002682 [DOI] [PubMed] [Google Scholar]
  145. Vitale S. A., Katz J. L. (2003). Liquid droplet dispersions formed by homogeneous liquid-liquid nucleation: “The Ouzo Effect.” Langmuir 19, 4105–4110 10.1021/la026842o15751338 [DOI] [Google Scholar]
  146. Weiss C. K., Landfester K. (2010). Miniemulsion polymerization as a means to encapsulate organic and inorganic materials. Adv. Polym. Sci. 233, 185–236 10.1007/12_2010_61 [DOI] [Google Scholar]
  147. Weiss C. K., Lorenz M. R., Mailänder V., Landfester K. (2007a). Cellular uptake behavior of unfunctionalized and functionalized pbca particles prepared in a miniemulsion. Macromol. Biosci. 7, 883–896 10.1002/mabi.200700046 [DOI] [PubMed] [Google Scholar]
  148. Weiss C. K., Ziener U., Landfester K. (2007b). A route to non-functionalized and functionalized poly (n-butylcyanoacrylate) nanoparticles: preparation in miniemulsion. Macromolecules 40, 928–938 10.1021/ma061865l [DOI] [Google Scholar]
  149. Westesen K., Bunjes H., Koch M. H. J. (1997). Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control. Release 48, 223–236 10.1016/S0168-3659(97)00046-1 [DOI] [Google Scholar]
  150. Wilbon P. A., Chu F., Tang C. (2013). Progress in renewable polymers from natural terpenes, terpenoids, and rosin. Macromol. Rapid Commun. 34, 8–37 10.1002/marc.201200513 [DOI] [PubMed] [Google Scholar]
  151. Wu D., Scott C., Ho C. C., Co C. C. (2006). Aqueous-core capsules via interfacial free radical alternating copolymerization. Macromolecules 39, 5848–5853 10.1021/ma060951i [DOI] [Google Scholar]
  152. Xu C., Miranda-Nieves D., Ankrum J. A., Matthiesen M. E., Phillips J. A., Roes I., et al. (2012). Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles. Nano Lett. 12, 4131–4139 10.1021/nl301658q [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Xu J., Singh A., Amiji M. M. (2014). Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer. BMC Cancer 14:75 10.1186/1471-2407-14-75 [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Yiamsawas D., Baier G., Thines E., Landfester K., Wurm F. R. (2014). Biodegradable lignin nanocontainers. RSC Adv. 4, 11661–11663 10.1039/c3ra47971d [DOI] [Google Scholar]
  155. Yoo H. S., Choi H.-K., Park T. G. (2001). Protein–fatty acid complex for enhanced loading and stability within biodegradable nanoparticles. J. Pharm. Sci. 90, 194–201 [DOI] [PubMed] [Google Scholar]
  156. Yu L., Dean K., Li L. (2006). Polymer blends and composites from renewable resources. Prog. Polym. Sci. 31, 576–602 10.1016/j.progpolymsci.2006.03.002 [DOI] [Google Scholar]
  157. Zaric M., Lyubomska O., Touzelet O., Poux C., Al-Zahrani S., Fay F., et al. (2013). Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated polyL-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS Nano 7, 2042–2055 10.1021/nn304235j [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Zhang S., Zou J., Zhang F., Elsabahy M., Felder S. E., Zhu J., et al. (2012). Rapid and versatile construction of diverse and functional nanostructures derived from a polyphosphoester-based biomimetic block copolymer system. J. Am. Chem. Soc. 134, 18467–18474 10.1021/ja309037m [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Zhi J., Wang Y., Luo G. (2005). Adsorption of diuretic furosemide onto chitosan nanoparticles prepared with a water-in-oil nanoemulsion system. React. Funct. Polym. 65, 249–257 10.1016/j.reactfunctpolym.2005.06.009 [DOI] [Google Scholar]
  160. Zini E., Gazzano M., Scandola M., Wallner S. R., Gross R. A. (2008). Glycolipid biomaterials: solid-state properties of a poly(sophorolipid). Macromolecules 41, 7463–7468 10.1021/ma800496f [DOI] [Google Scholar]
  161. Zur Mühlen A., Mehnert W. (1998). Drug release and release mechanisms of prednisolone loaded solid lipid nanoparticles. Pharmazie 2, 552–555 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Chemistry are provided here courtesy of Frontiers Media SA

RESOURCES